WWW - Posts tagged Access pharmaceuticals at BloggingStocks

access pharmaceuticals posts

Newspaper wrap-up: Pepsi (PEP) to launch diet Gatorade

MAJOR PAPERS:

"The behavior in what we are observing in the last seven weeks is identical in many respects to what we saw in 1998, what we saw in the stock market crash of 1987, I suspect what we saw in the land boom collapse of 1837 and certainly [the bank panic] 1907," said Alan Greenspan, the former Federal Reserve chairman, reported the Wall Street Journal.
In an attempt to reverse slow North American sales of Gatorade, PepsiCo Inc (NYSE: PEP) is launching a low calorie version, reported the Wall Street Journal.

OTHER PAPERS:

British arms manufacturer BAE Systems (OTC: BAESY) will reportedly receive a GBP20B deal next week to supply 72 Eurofighter Typhoon jets to Saudi Arabia, reported the U.K. Times.
British telecom company Vodafone Group (NYSE: VOD) is considering buying the Italian and Spanish operations of Swedish telecom company Tele2, reported the Guardian.
From BusinessWeek's "Inside Wall Street" column:

NYSE Euronext Inc (NYSE: NYX) runs cash equity exchanges in five countries and six derivative markets worldwide, and Birkelbach Investment Securities feels the stock is "very undervalued."
The outlook for Access Pharmaceuticals Inc (NASDAQ: ACCP) and ProLindac has vastly improved, said Steven Rouhandeh, CEO of SCO Financial Group, which owns a 30% stake in the company.
NeoStem Inc (NYSE: NBS) is a tiny company that specializes in collecting, processing, and storing stem cells from healthy adults for their personal medical use, and Equity Dynamics is positive on the company's technology.